Search results
Results from the WOW.Com Content Network
The blue tilapia (Oreochromis aureus) is a species of tilapia, a fish in the family Cichlidae. [2] Native to Northern and Western Africa, and the Middle East, through introductions it is now also established elsewhere, including parts of the United States, where it has been declared an invasive species and has caused significant environmental damage. [3]
Tilapia (/ t ɪ ˈ l ɑː p i ə / tih-LAH-pee-ə) is the common name for nearly a hundred species of cichlid fish from the coelotilapine, coptodonine, heterotilapine, oreochromine, pelmatolapiine, and tilapiine tribes (formerly all were "Tilapiini"), with the economically most important species placed in the Coptodonini and Oreochromini. [2]
Some make use of SBRT (stereotactic body radiation therapy), a very precise radiation technique able to provide high doses with minimal side effects. Most trials of LCT in NSCLC focus on oligometastatic disease (under 3-5 lesions, depending on the definitions), but preliminary results of the BRIGHTSTAR trial [ 24 ] indicate this method may be ...
Oreochromis contains more than 30 species, and several undescribed forms exist. Judging from mtDNA sequence analysis, several clades seem to exist. Research is hampered because hybridization runs rampant in these fishes, which confounds mtDNA data ( Wami tilapia is an example), and the fast speed of evolution makes choice of appropriate nuclear ...
O. aureus may refer to: Oreochromis aureus, a species of fish also known as the blue tilapia. Ornithinibacter aureus, a Gram-positive bacterium.
Pulmonary toxicity is the medical name for side effects on the lungs. Although most cases of pulmonary toxicity in medicine are due to side effects of medicinal drugs, many cases can be due to side effects of radiation (radiotherapy). Other (non-medical) causes of pulmonary toxicity can be chemical compounds and airborne particulate matter.
Other side effects of gold-containing drugs include kidney damage, itching rash, and ulcerations of the mouth, tongue, and pharynx. Approximately 35% of patients discontinue the use of gold salts because of these side effects. Kidney function must be monitored continuously while taking gold compounds. [5]
NVL-655 is a fourth generation targeted therapy (currently in clinical trials), developed by Nuvalent. [14] [15] Although treatment with immune checkpoint inhibitors has proved effective with some types of non-small cell lung cancer, it seems to be generally ineffective with ALK positive non-small cell lung cancer. [16]